Zobrazeno 1 - 10
of 1 026
pro vyhledávání: '"serious infection"'
Autor:
Ana Luisa Bagno de Almeida, Maria Fernanda B. Resende Guimarães, Maria Raquel da Costa Pinto, Leticia Rocha Pereira, Ana Paula Monteiro Gomides Reis, Karina Rossi Bonfiglioli, Paulo Louzada-Junior, Rina Dalva Neubarth Giorgi, Gláucio Ricardo Werner de Castro, Sebastião Cezar Radominski, Claiton Viegas Brenol, Alisson Pugliesi, Licia Maria Henrique da Mota, Geraldo da Rocha Castelar-Pinheiro
Publikováno v:
Advances in Rheumatology, Vol 64, Iss 1, Pp 1-8 (2024)
Abstract Background Infections increase mortality and morbidity and often limit immunosuppressive treatment in rheumatoid arthritis patients. Objective To analyze the occurrence of serious infections and the associated factors in a cohort of rheumato
Externí odkaz:
https://doaj.org/article/28908bb3abb34a799be77d7f47611870
Autor:
Wen-Nan Huang, Ching-Yi Chuo, Ching-Heng Lin, Yi-Ming Chen, Wei-Szu Lin, Katie Tuckwell, Nicholas S. Jones, Joshua Galanter, Lisa Lindsay
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 2, Pp 387-404 (2022)
Abstract Introduction Serious infections are an important concern for patients with autoimmune conditions. We sought to estimate serious infection rates among patients with select autoimmune conditions relative to the general population in Taiwan and
Externí odkaz:
https://doaj.org/article/f80d9b45c933432c9cd5346d63b31b8c
Autor:
Claudia A. Salinas, Anthony Louder, Jennifer Polinski, Tancy C. Zhang, Hannah Bower, Syd Phillips, Yufei Song, Emaan Rashidi, Rafia Bosan, Hsiu-Ching Chang, Nicole Foster, Bernice Gershenson, Hisashi Yamanaka, Mitsumasa Kishimoto, Yoshiya Tanaka, Peter Fischer, Baojin Zhu, Douglas Faries, Xiaodan Mai, Brett T. Doherty, Angela Grelaud, Nicolas H. Thurin, Johan Askling, Walter Deberdt, the B023 Study Consortium
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 1, Pp 201-223 (2022)
Abstract Introduction The aim of this work is to evaluate baricitinib safety with respect to venous thromboembolism (VTE), major adverse cardiovascular events (MACE), and serious infection relative to tumor necrosis factor inhibitors (TNFi) in patien
Externí odkaz:
https://doaj.org/article/0ffed6005506402cb9e808540e503b79
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-5 (2022)
Abstract Background Postpolypectomy fever (PPF) is a rare complication in patients after colonoscopy. Because of the absence of evidence of microperforation and abdominal tenderness, patients with PPF usually present mild clinical symptoms with a goo
Externí odkaz:
https://doaj.org/article/367996bc60204700865393f98ac14a78
Publikováno v:
mBio, Vol 14, Iss 1 (2023)
ABSTRACT Serious infections are characterized by rapid progression, poor prognosis, and difficulty in diagnosis. Recently, a new technique known as nanopore-targeted sequencing (NTS) was developed that facilitates the rapid and accurate detection of
Externí odkaz:
https://doaj.org/article/b7469b3fbe804b24a46dd6128691144e
Publikováno v:
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-9 (2021)
Abstract Background To evaluate incidence of opportunistic infections (OIs) in patients with rheumatoid arthritis (RA) treated with abatacept in clinical trials. Methods This pooled analysis of 16 randomized, double-blind/open-label trials, with ≥
Externí odkaz:
https://doaj.org/article/cd8dfbb3f012421b82cabd030ac92a0c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Leslie R. Harrold, Heather J. Litman, Katherine C. Saunders, Kimberly J. Dandreo, Bernice Gershenson, Jeffrey D. Greenberg, Robert Low, Jeffrey Stark, Robert Suruki, Srihari Jaganathan, Joel M. Kremer, Mohamed Yassine
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-11 (2018)
Abstract Background Registry studies provide a valuable source of comparative safety data for tumor necrosis factor inhibitors (TNFi) used in rheumatoid arthritis (RA), but they are subject to channeling bias. Comparing safety outcomes without accoun
Externí odkaz:
https://doaj.org/article/b0086cce10b7407b95e3ca6a90f94d2f